274 related articles for article (PubMed ID: 9879288)
21. Quantitation of alpha-fetoprotein messenger RNA for early detection of recurrent hepatocellular carcinoma: a prospective pilot study.
Schmilovitz-Weiss H; Stemmer SM; Liberzon E; Avigad S; Sulkes J; Belinki A; Kazatsker A; Ben-Ari Z
Cancer Detect Prev; 2006; 30(2):204-9. PubMed ID: 16638626
[TBL] [Abstract][Full Text] [Related]
22. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
[TBL] [Abstract][Full Text] [Related]
23. [Perioperative detection of MAGE-1mRNA and AFP mRNA in peripheral blood of patients with hepatocellular carcinoma: relationships with recurrence].
Yang SZ; Dong JH; Zhu J; Li K; Zhang Y
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(9):595-8. PubMed ID: 15949354
[TBL] [Abstract][Full Text] [Related]
24. Human telomerase reverse transcriptase messenger RNA (TERT mRNA) as a tumour marker for early detection of hepatocellular carcinoma.
El-Mazny A; Sayed M; Sharaf S
Arab J Gastroenterol; 2014 Jun; 15(2):68-71. PubMed ID: 25097049
[TBL] [Abstract][Full Text] [Related]
25. Circulating prostate-specific antigen mRNA during radical prostatectomy in patients with localized prostate cancer: with special reference to neoadjuvant hormonal therapy.
Ogawa O; Iinuma M; Sato K; Sasaki R; Shimoda N; Satoh S; Kato T
Urol Res; 1999 Aug; 27(4):291-6. PubMed ID: 10460902
[TBL] [Abstract][Full Text] [Related]
26. Quantitative real-time rt-PCR for detection of circulating prostate-specific antigen mRNA using sequence-specific oligonucleotide hybridization probes in prostate cancer patients.
Straub B; Müller M; Krause H; Schrader M; Miller K
Oncology; 2003; 65 Suppl 1():12-7. PubMed ID: 12949428
[TBL] [Abstract][Full Text] [Related]
27. [Detection of PSA mRNA from the peripheral blood and pelvic lymph nodes in patients with prostatic cancer by means of reverse transcription-polymerase chain reaction (RT-PCR)].
Mao H; Hoshi S; Takahashi T; Kaneda T; Wang J; Suzuki K; Orikasa S
Nihon Hinyokika Gakkai Zasshi; 1998 Jun; 89(6):596-603. PubMed ID: 9666686
[TBL] [Abstract][Full Text] [Related]
28. A study of diagnostic value of golgi protein GP73 and its genetic assay in primary hepatic carcinoma.
Shi Y; Chen J; Li L; Sun Z; Zen L; Xu S; Zhang Y; Zhang L
Technol Cancer Res Treat; 2011 Jun; 10(3):287-94. PubMed ID: 21517136
[TBL] [Abstract][Full Text] [Related]
29. Quantitative comparison of alpha-fetoprotein and albumin mRNA levels in hepatocellular carcinoma/adenoma, non-tumor liver and blood: implications in cancer detection and monitoring.
Wong IH; Lau WY; Leung T; Johnson PJ
Cancer Lett; 2000 Aug; 156(2):141-9. PubMed ID: 10880763
[TBL] [Abstract][Full Text] [Related]
30. [The detection of circulating hepatocellular carcinoma cells in peripheral venous blood by reverse transcription-polymerase chain reaction and its clinical significance].
Liu Y; Zhang B; Qian G; Chen H; Wu M; Fu J; Huang C
Zhonghua Wai Ke Za Zhi; 1998 Oct; 36(10):608-10. PubMed ID: 11825477
[TBL] [Abstract][Full Text] [Related]
31. AFP mRNA level in enriched circulating tumor cells from hepatocellular carcinoma patient blood samples is a pivotal predictive marker for metastasis.
Jin J; Niu X; Zou L; Li L; Li S; Han J; Zhang P; Song J; Xiao F
Cancer Lett; 2016 Aug; 378(1):33-7. PubMed ID: 27160647
[TBL] [Abstract][Full Text] [Related]
32. [Detection of prostate-specific antigen mRNA in preoperative peripheral blood of patients with prostate cancer: relationship to pathological parameters of the surgical specimens].
Iinuma M; Sato K; Ogawa O; Sasaki R; Kato T
Nihon Hinyokika Gakkai Zasshi; 1999 May; 90(5):548-56. PubMed ID: 10386054
[TBL] [Abstract][Full Text] [Related]
33. A prospective study of blood alpha-fetoprotein messenger RNA as a predictor of hepatocellular carcinoma in patients with cirrhosis.
Iavarone M; Lampertico P; Ronchi G; Del Ninno E; Zanella A; Colombo M
J Viral Hepat; 2003 Nov; 10(6):423-6. PubMed ID: 14633174
[TBL] [Abstract][Full Text] [Related]
34. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.
Kamiyama T; Takahashi M; Nakagawa T; Nakanishi K; Kamachi H; Suzuki T; Shimamura T; Taniguchi M; Ozaki M; Matsushita M; Furukawa H; Todo S
Ann Surg; 2006 Sep; 244(3):451-63. PubMed ID: 16926571
[TBL] [Abstract][Full Text] [Related]
35. Determination of prostate specific antigen mRNA in peripheral blood by reverse transcriptase polymerase chain reaction and a simple chemiluminometric hybridization assay in a high-throughput format.
Emmanouilidou E; Ioannou PC; Christopoulos TK; Polizois K
Anal Biochem; 2003 Feb; 313(1):97-105. PubMed ID: 12576064
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of reverse transcriptase polymerase chain reaction for prostate-specific antigen in men with hormone-refractory prostate cancer.
Kantoff PW; Halabi S; Farmer DA; Hayes DF; Vogelzang NA; Small EJ
J Clin Oncol; 2001 Jun; 19(12):3025-8. PubMed ID: 11408497
[TBL] [Abstract][Full Text] [Related]
37. Numeric definition of the clinical performance of the nested reverse transcription-PCR for detection of hematogenous epithelial cells and correction for specific mRNA of non-target cell origin as evaluated for prostate cancer cells.
Schamhart D; Swinnen J; Kurth KH; Westerhof A; Kusters R; Borchers H; Sternberg C
Clin Chem; 2003 Sep; 49(9):1458-66. PubMed ID: 12928226
[TBL] [Abstract][Full Text] [Related]
38. Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages.
Corey E; Arfman EW; Oswin MM; Melchior SW; Tindall DJ; Young CY; Ellis WJ; Vessella RL
Urology; 1997 Aug; 50(2):184-8. PubMed ID: 9255285
[TBL] [Abstract][Full Text] [Related]
39. Detecting AFP mRNA in peripheral blood of the patients with hepatocellular carcinoma, liver cirrhosis and hepatitis.
Yao F; Guo JM; Xu CF; Lou YL; Xiao BX; Zhou WH; Chen J; Hu YR; Liu Z; Hong GF
Clin Chim Acta; 2005 Nov; 361(1-2):119-27. PubMed ID: 15993394
[TBL] [Abstract][Full Text] [Related]
40. TPA, TATI, CEA, AFP, beta-HCG, PSA, SCC, and CA 19-9 for monitoring transitional cell carcinoma of the bladder.
Pectasides D; Bafaloucos D; Antoniou F; Gogou L; Economides N; Varthalitis J; Dimitriades M; Kosmidis P; Athanassiou A
Am J Clin Oncol; 1996 Jun; 19(3):271-7. PubMed ID: 8638540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
